Article Text
Abstract
Human tissue and body parts have been used in one way or another for millennia. They have been preserved and displayed, both in museums and public shows. Real human hair is used for wigs, while some artists even use human tissue in their works. Blood, bone marrow, whole organs and a host of other structures and human substances are all transplanted into living persons to treat illness. New life can be created from gametes through in vitro fertilisation (IVF), while the creation of cell lines keeps tissue alive indefinitely. These uses create significant challenges for the legal system in the UK. The major challenge for the law is to balance the competing demands of those groups who have vested interests in human tissue—researchers, medical practitioners, patients, families, the community and the police, among many others. It must provide sufficient control to users of tissue, but also take account of the fact that our bodies hold psychological importance for us while we live and, after we die, for those we leave behind. To some degree the law has been successful, but we still lack a comprehensive, coherent approach to the regulation of human tissue. Partially as a reaction to this lack of a comprehensive approach, some commentators have turned to applying the concept of property to human tissue means to achieve regulatory outcomes they support.
- Donation/Procurement of Organs/Tissues
- Bills, Laws and Cases
- History of Health Ethics/Bioethics
- Law
- Legal Aspects
Statistics from Altmetric.com
Request Permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information:
Linked Articles
- The concise argument
Read the full text or download the PDF:
Other content recommended for you
- Using human tissue: when do we need consent
- Observational retrospective study of UK national success, risks and costs for 319,105 IVF / ICSI and 30,669 IUI treatment cycles
- Social egg freezing and donation: waste not, want not
- A pilot double - blind randomised placebo - controlled dose – response trial assessing the effects of melatonin on infertility treatment (MIART): study protocol
- Obtaining explicit consent for the use of archival tissue samples: practical issues
- The need for donor consent in mitochondrial replacement
- Britain ’s new preimplantation tissue typing policy: an ethical defence
- Human tissue models for a human disease: what are the barriers
- Ethics briefings
- Intracytoplasmic sperm injection and other aspects of new reproductive technologies